Circulating IgA endomysial antibodies (EMA) are present in 70 to 80% of patients with Celiac disease and Dermatitis herpetiformis. This assay is useful in the evaluation of these diseases. It also monitors adherence to a gluten-free diet. The titer generally correlates with the degree of mucosal damage and decreases with adherence to a strict gluten-free diet.